Suven Life Sciences announces first patient randomized in Phase-2b clinical trial of Ropanicant
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
This marks the fourth acquisition by Corona Remedies from multinational corporations
Celecoxib is a nonsteroidal anti-inflammatory drug
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Capricor’s BLA for Deramiocel received Priority Review in March 2025
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
It is intended for contrast enhancement in MRI scans
Subscribe To Our Newsletter & Stay Updated